Medworxx
Solutions Inc. ("Medworxx") (TSX VENTURE:MWX)
today announced Basildon and Thurrock University Hospitals NHS
Foundation Trust (BTUH) has licensed the Medworxx Clinical Criteria
Module to be installed in a multi-phase Clinical Utilisation Review
(CUR) deployment across the Acute Trust and ultimately into neighbouring
Community based services, covering close to 700 beds across several
locations. BTUH has been successfully appointed by NHS England as an
early Implementer of the National CUR CQUIN Scheme and provides an
extensive range of acute services for 405,000 people living in
south-west Essex. The Essex
Cardiothoracic Centre is also part of the Trust, providing a full
range of tertiary cardiothoracic services for the whole county and
further afield. Phase one of the locally hosted implementation includes
a strategic rollout across the Cardiothoracic Centre’s three wards, with
Phase two including all general medicine beds.
BTUH’s decision to license Medworxx came as a result of a CUR snapshot
audit, delivered in February 2015. The results identified opportunities
for whole system patient flow improvement which were shared with the
local System Resilience Group, and provided decision makers with the
necessary evidence to select the Medworxx Clinical Criteria Module -
designed to provide advanced patient flow analytics in real-time to
support improvements in MDT discharge and system integration. In 2014
NHS England introduced a substantial Commissioning for Quality and
Innovation scheme (CQUIN) to support providers in adopting CUR
technology for specialised admitted patient care and critical care in
2015/16.
The goal of the CUR CQUIN is to improve patient flow, enhance quality
and ensure patients are treated in the most appropriate clinical
settings, freeing up staff time and hospital resources. BTUH represents
one of five Trusts selected by NHS England to be early CQUIN adopters.
Medworxx currently supports three of the five adopters, who have all
selected to utilise the Medworxx patient flow software for CUR. “We are
eager to utilise our CQUIN funding. Our partnership with Medworxx showed
us how resources, as reported in the diagnostic review, can be sustained
and built upon by embedding the Medworxx tool as part of our current
clinical utilisation program,” said Nigel Kee, Chief Operating Officer,
Basildon and Thurrock University Hospitals NHS Foundation Trust.
“This is an exciting time for Medworxx and for CUR development in the
UK. We welcome BTUH to our client community, as we work together to
standardise admit and discharge decision making for appropriateness of
inpatients,” said Dan Matlow, President and Chief Executive Officer,
Medworxx. “For the first time, BTUH will be able to conduct rapid
assessments and collect transparent information and data on individual
patient progress and discharge planning in real-time.”
About Medworxx
Medworxx delivers health information
technology solutions to over 400 hospitals internationally; including
Canada, France, United States and United Kingdom. Medworxx helps
hospitals meet patient flow challenges, and requirements in compliance
and education. Medworxx Utilisation Management—flagship of Medworxx
Patient Flow that includes electronic bed board and independent
assessment components—currently serves 32%of the acute care beds in
Canada.
Visit: http://www.medworxx.com/
Disclaimer
The statements made in this press
release may contain forward-looking statements that may involve a number
of risks and uncertainties. Actual events or results could differ
materially from the company’s expectations and projections. The TSX
Venture Exchange has not reviewed this press release and neither
approved nor disapproved the information contained in this press release.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20150707006573r1&sid=ntxv4&distro=nx&lang=en)
View source version on businesswire.com: http://www.businesswire.com/news/home/20150707006573/en/
Copyright Business Wire 2015